denileukin diftitox   Click here for help

GtoPdb Ligand ID: 7044

Synonyms: DAB389 IL2 | denileukin diftitox-cxdl | LY 335348 | Lymphir® | Ontak®
Approved drug Immunopharmacology Ligand
denileukin diftitox is an approved drug (FDA (1999))
Compound class: Peptide
Comment: Denileukin diftitox is an anti-cancer immunotherapy drug that was designed to target and eradicate malignant (IL-2 receptor-expressing) T cells. It is a recombinant protein containing peptide sequences of both interleukin-2 and diphtheria toxin [1,5]. It simultaneously directly kills IL-2R expressing tumour cells and promotes depletion of host Treg cells which enhances the immune response

For advanced searching click here to open chemical structure editor

Other Similar Sequences Click here for help
IL-2  {Sp: Human}
Targets
Interleukin-2 receptor
bempegaldesleukin
Targets
Interleukin-2 receptor subunit β